- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06251791
Inspiratory Muscle Training and Expiratory Muscle Thickness
February 10, 2024 updated by: Reyhan Kaygusuz, Istanbul Demiroglu Bilim University
Exploring The Impact Of Inspiratory Muscle Training on Expiratory Muscle Thickness During Intensive Care Patients
the specific effect of IMT on expiratory muscle strength and abdominal wall thickness during weaning remains unclear.
To address this significant research gap, the primary objective of our study was to evaluate the effect of IMT after extubation on expiratory muscle strength and abdominal muscle thickness in respiratory ICU patients.
On the other hand the investigators established reference values for ultrasonographic measurements in healthy control subjects as a comparative arm.
To the best of our knowledge, this is the first study to examine the ultrasonographic effects of IMT on the expiratory muscle thickness after extubation.
The investigators believe that our study may contribute to related literature in this context and guide future research as a pioneer with its unique value.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
the specific effect of IMT on expiratory muscle strength and abdominal wall thickness during weaning remains unclear.
To address this significant research gap, the primary objective of our study was to evaluate the effect of IMT after extubation on expiratory muscle strength and abdominal muscle thickness in respiratory ICU patients.
On the other hand the investigators established reference values for ultrasonographic measurements in healthy control subjects as a comparative arm.
To the best of our knowledge, this is the first study to examine the ultrasonographic effects of IMT on the expiratory muscle thickness after extubation.
The investigators believe that our study may contribute to related literature in this context and guide future research as a pioneer with its unique value.
In this single-blind randomized controlled study, 20 patients were divided into two groups: IMT and conventional physiotherapy(CP).
In order to establish normative data for abdominal muscle thickness, ten healthy controls were included in the study.
The CP group received CP and the IMT group received CP+IMT for five days following extubation.
The thicknesses of the external oblique abdominal(EOA),internal oblique sbdominal(IOA), transversus abdominus (TRA) and rectus abdominis (RA) muscleswere evaluated The maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP) were recorded.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Şişli
-
Istanbul, Şişli, Turkey
- Istanbul Demiroglu University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
For Patients Group Inclusion Criteria:
- Needing mechanical ventilation support longer than 2 days,
- Alert and Riker Sedation Agitation Score >4
- Being hemodynamically stable (HR<140 beats/min, BP stable)
- Dobutamine and minimal vasopressor use
- Fever of 36.5-38.5
- Body Mass Index <40 m2/cm,
- FiO2 of 0.5 or less,
- Absence of myocardial ischemia.
Exclusion Criteria:
For Patients Group Exclusion Criteria:
- Noncooperation
- Phrenic nerve damage
- Chest wall trauma and/or deformity to prevent diaphragmatic movement
- Progressive neuromuscular disease with respiratory involvement
- There is enough secretion to require more than one aspiration every hour.
- Patients using sedative drugs continuously
- High-dose cortisol use
- Using a home mechanical ventilator before mechanical ventilation in intensive care unit
For Healthy Group Inclusion Criteria:
- With the control and intervention group, age, characteristics and characteristics,
- Chronic system and no ongoing treatment,
- Body mass index not 40 kg/m2,
- 18-80 years old
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental
Experimental: Conventional Physiotherapy In the intensive care unit and who had mechanical ventilation for more than 48 hours and who were extubated.
In this group addition to conventional physiotherapy inspiratory muscle training will be performed with the threshold-loaded inspiratory muscle training device, starting at 30% of the maximum inspiratory mouth pressure value, during 5 days, in 2 sessions, 4 sets per day, 6-8 breaths in each set and 2 minutes of rest between sets.
|
Conventional Physiotherapy to contain breathing and thoracal expansion exercises, bronchial hygiene techniques and gradual mobilization in 1 time a day.
Conventional Physiotherapy to contain breathing and thoracal expansion exercises, bronchial hygiene techniques and gradual mobilization in 1 time a day.
In this group addition to conventional physiotherapy inspiratory muscle training will be performed with the threshold-loaded inspiratory muscle training device, starting at 30% of the maximum inspiratory mouth pressure value, during 5 days, in 2 sessions, 4 sets per day, 6-8 breaths in each set and 2 minutes of rest between sets.
|
Experimental: Conventional
In this group will apply only conventional physiotherapy.
Conventional physiotherapy to contain breathing and,thoracal expansion exercises, bronchial hygiene techniques and gradual mobilization.
Conventional physiotherapy apply for 5 days after extubation period 1 time a day.
|
Conventional Physiotherapy to contain breathing and thoracal expansion exercises, bronchial hygiene techniques and gradual mobilization in 1 time a day.
Conventional Physiotherapy to contain breathing and thoracal expansion exercises, bronchial hygiene techniques and gradual mobilization in 1 time a day.
|
No Intervention: Healthy controls
There is no intervention in this group.
Baseline measurements are to compare with experimental groups.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Abdominal Muscle Thickness
Time Frame: Change from baseline Maximal inspiratory and expiratory pressure at 5th day]
|
Eksternal Oblique, Internal Oblique, Transverses Abdominus and rectus abdominus Ultrasonografic mesasurements
|
Change from baseline Maximal inspiratory and expiratory pressure at 5th day]
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maximal inspiratory and expiratory pressure
Time Frame: Change from baseline Maximal inspiratory and expiratory pressure at 5th day]
|
Intraoral pressures measured at maximal respiration against a valve that closes the airway during maximal inspiration pressure and expiration.
Maximal inspiration pressure is the highest pressure created to open closed alveoli at the residual volume level.
In our study, respiratory muscle strength will be performed using a portable, electronic mouth pressure measuring with device.
For the test, the applied person is given maximum expiration and at the end of this, the airway is closed with a valve and the person is asked to make maximum inspiration and continue it for 1-3 seconds.
In the maximal expiration pressure measurement, after maximal inspiration, the person is asked to make a maximal expiration for 1-3 seconds against the closed airway.
The best of the three measurements is selected.
There should be no more than 10% or more than 10 cmH2O difference between the two best measured
|
Change from baseline Maximal inspiratory and expiratory pressure at 5th day]
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: barış yılmaz, MD, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2021
Primary Completion (Actual)
December 1, 2022
Study Completion (Actual)
November 1, 2023
Study Registration Dates
First Submitted
February 1, 2024
First Submitted That Met QC Criteria
February 1, 2024
First Posted (Actual)
February 9, 2024
Study Record Updates
Last Update Posted (Estimated)
February 13, 2024
Last Update Submitted That Met QC Criteria
February 10, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IMT on abdominal muscle
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Muscle Weakness
-
St. Luke's-Roosevelt Hospital CenterCompletedFall Risk | Quadriceps Muscle Weakness | Adductor Muscle WeaknessUnited States
-
University of Central ArkansasCompletedPelvic Floor Muscle WeaknessUnited States
-
Association Pro-arteActive, not recruitingWeakness, Muscle | AmyotrophiaFrance
-
Ludwig Boltzmann Institute of Electrical Stimulation...Medical University of Vienna; European Union; Comenius University; Ministry of...CompletedMuscle Weakness Condition | Therapy EffectAustria, Slovakia
-
Rutgers, The State University of New JerseyRecruitingPhysical Disability | Muscle Atrophy or Weakness | Muscle Loss | Physical Inactivity | Delirium in Old Age | Hospital Acquired Condition | Weakness, MuscleUnited States
-
University of MilanCompleted
-
University of Central FloridaCompletedMuscle Weakness | Muscle Atrophy | Muscle Loss | Weakness, Muscle | Injury, KneeUnited States
-
University of Texas Southwestern Medical CenterTerminatedMuscle Cramp | Statin Adverse Reaction | Weakness, Muscle | AcheUnited States
-
Damanhour UniversityCompletedNeuromuscular Electrical Stimulation | ICU Acquired Muscle WeaknessEgypt
-
Messiah CollegeNot yet recruiting
Clinical Trials on conventional physiotherapy+ IMT
-
Hospital de Clinicas de Porto AlegreRecruitingChronic Obstructive Pulmonary DiseaseBrazil
-
Universitair Ziekenhuis BrusselHasselt University; Jessa HospitalWithdrawnPhysiotherapy | Coronary Artery Bypass Graft Surgery | Valve Replacement | Post-Op Complications
-
Universidade Federal do vale do São FranciscoRecruiting
-
Aalborg University HospitalKU Leuven; Örebro University, Sweden; Region Örebro CountyCompletedLung Cancer | SurgeryDenmark
-
University of SalamancaRecruiting
-
Pamukkale UniversityCompletedChronic Low-back PainTurkey
-
University of LahoreRecruitingHypotonic Cerebral PalsyPakistan
-
Eastern Mediterranean UniversityCompletedCervical SpondylosisCyprus
-
Cairo UniversityRecruitingIntensive Care Unit Acquired WeaknessEgypt
-
Bezmialem Vakif UniversityCompleted